fbpx
(714) 942-0522

Dr. Sonia Badreshia-Bansal, MD

14591 Newport Ave Suite 102 Tustin, CA 92780
hello@beautybungalowsculpting.com

Tirzepatide

Tirzepatide is a groundbreaking treatment for type 2 diabetes and weight loss. It helps lower blood sugar levels and reduce hunger, making it easier to lose weight. Tirzepatide is unique because it combines the effects of two natural hormones that regulate your blood sugar and appetite.

This medication works by:

•Helping your body release insulin when your blood sugar is high.

•Slowing down how quickly food leaves your stomach, so you feel fuller longer.

•Sending signals to your brain to reduce cravings and eat less.

Tirzepatide is an effective option for people looking to manage their weight or blood sugar, and it’s prescribed as part of a medically supervised plan.

Tirzepatide is a once-weekly injectable medication, FDA-approved and manufactured to the highest standards, offering exceptional results in lowering blood sugar levels and promoting significant weight loss. At Beauty Bungalow, this treatment is administered by our Physician Assistant, Nicole, under the supervision of Dr. Sonia Badreshia-Bansal, MD. A consultation is required before starting to ensure this treatment is safe and suitable for your health needs.

Why Choose Beauty Bungalow for Tirzepatide?

At Beauty Bungalow, we provide a personalized, medically supervised experience to help you reach your health and weight-loss goals safely. Contact us today to book your consultation and begin your journey to better health.

Frequently Asked Questions

Tirzepatide is delivered as a once-weekly injection. Our team will guide you on how to use it properly at home or provide in-office administration.

Some patients report noticeable weight loss within the first few weeks. For best results, we recommend a consistent treatment plan combined with a healthy lifestyle.

While both medications target weight loss and appetite control, tirzepatide has a dual-action mechanism affecting two hormones (GLP-1 and GIP), while semaglutide only targets GLP-1.